Flash Glucose Monitoring will today (1 November) be made available on prescription through the NHS.
Diabetes UK is calling on local decision makers to draw up policies designed to ensure that those who will benefit clinically from this technology will be able to access it.
Helen Dickens is Assistant Director of Campaigns and Mobilisation at Diabetes UK. She said:
“We were delighted that Flash Glucose Monitoring (Flash GM) was approved for use in the NHS. This was the result of a lot of hard work from people with diabetes, Diabetes UK and other professional organisations and charities.
“People with diabetes have since been looking forward to Flash GM getting onto the NHS Tariff. However, many are already sharing their frustrations that they are being told the chances of accessing the technology in their local areas will be very slim.
“It’s vital that local areas develop policies that enable access to Flash GM for those groups that would most benefit. We expect them to work with health professionals and people with diabetes in developing these policies.
“We do not believe there is any justification for placing blanket bans on accessing the technology. Each area should develop a policy and, where people can prove they would benefit clinically, the tech should be prescribed.
“Diabetes UK will continue to work with people, healthcare professionals, JDRF and INPUT to highlight issues in accessing Flash GM and champion access to technology that helps people manage their diabetes better.”
To join the campaign to help make access to flash a reality go to our flash glucose monitoring campaign page.